Proposed
Bill · 119th Congress · HR 2343
John W. Walsh Alpha-1 Home Infusion Act of 2025
Refreshed 1 h ago
Introduced 2025-03-25Topic: health careSummary
Summary by the Congressional Research ServiceJohn W. Walsh Alpha-1 Home Infusion Act of 2025 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
Sponsors
- Maria Elvira Salazar Republican sponsor
- 60 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2025-03-25 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2025-03-25 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | refer |
| 2025-03-25 | Introduced in House | introduce | |
| 2025-03-25 | Introduced in House | introduce |